PerkinElmer, Inc. Introduces New Multispecies In Vivo Imaging Solution for Drug Development at American Association for Cancer Research Annual Meeting

ORLANDO, Fla.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced a new Multispecies Imaging Module (MSIM) for PerkinElmer’s Fluorescence Molecular Tomography In Vivo Imaging Systems (FMT® 1500 or FMT® 2500LX). The new module enables researchers to generate 3D datasets of animal models relevant to disease research, including imaging capability for larger animals.